Pentoxifylline attenuates bacterial lipopolysaccharide-induced enhancement of allyl alcohol hepatotoxicity

Toxicological Sciences

Volumn 56, Issue 1, 2000, Pages 203-210

  Sneed, Rosie A ^a   Buchweitz, John P ^a   Jean, Paul A ^a   Ganey, Patricia E ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Allyl alcohol; Kupffer cells; Liver damage; Tumor necrosis factor alpha (TNF )

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL DEHYDROGENASE; ALLYL ALCOHOL; BACTERIUM LIPOPOLYSACCHARIDE; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE TIME EFFECT RELATION; KUPFFER CELL; LIVER CELL CULTURE; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; NONHUMAN; RAT;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0033921497     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/56.1.203     Document Type: Article

References (58)

1. Adamson, G. M., and Billings, R. E. (1992). Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes. Arch. Biochem. Biophys. 294, 223-229.
2. Beutler, B., Milsark, I. W., and Cerami, A. C. (1985). Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229, 869-871.
3. Bouwens, L., and Wisse, E. (1992). The origin of Kupffer cells and their anatomic relationship to hepatocytes. In Hepatocytes and Kupffer Cell Interactions (T. Billiar and R. D. Curran, Eds.), pp. 4-19. CRC Press, Boca Raton.
4. Brown, A. P., Harkema, J. R., Schultze, A. E., Roth, R. A., and Ganey, P. E. (1997). Gadolinium chloride pretreatment protects against hepatic injury but predisposes the lungs to alveolitis following lipopolysaccharide administration. Shock 7, 186-192.
5. Calcamuggi, G., Lanzio, M., Dughera, L., Babini G., and Emanuelli, G. (1992). Endotoxin tolerance and polymyxin B modify liver damage and cholestasis induced by a single dose of alpha-naphthylisothiocyanate in the rat. Arch. Toxicol. 66, 126-30.
6. Chamulitrat, W., Jordan, S. J., and Mason, R. P. (1994). Nitric oxide production during endotoxic shock in carbon tetrachloride-treated rats, Mol. Pharmacol. 46, 391-397.
7. Chang, H. R., Vesin, C. Grau, G. E., Pointaire, P., Arsenijevic, D., Strath, M., Pechere, J. C., and Piguet, P. F. (1993). Respective role of polymorphonuclear leukocytes and their integrins (CD-11/18) in the local or systemic toxicity of lipopolysaccharide. J. Leukoc. Biol. 53, 636-639.
8. Dahm, L. J., Schultze, A. E., and Roth, R. A. (1991). An antibody to neutrophils attenuates α-naphthylisothiocyanate-induced liver injury. J. Pharmacol. Exp. Ther. 256, 412-420.
9. Decker, K. (1990). Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192, 245-261.
10. Dezube, B. J., Sherman, M. L., Fridovich-Keil, J. L., Allen-Ryan, J., and Pardee, A. B. (1993). Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot study. Cancer Immunol. Immunother. 36, 57-60.
11. Doherty, G. M., Jensen, J. C., Alexander, H. R., Buresh, C. M., and Norton, J. A. (1991). Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110, 192-198.
12. Eskandari, M. K., Nguyen, D. T., Kunkel, S. L., and Remick, D. G. (1990). WEHI 164 subclone 13 assay for TNFα: sensitivity, specificity, and reliability. Immunol. Invest 19, 69-79.
13. Espevik, T., and Nissen-Meyer, J. (1986). A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95, 99-105.
14. Feingold, K. R., Staprans, I., Memon, R. A., Moser, A. H., Shigenaga, J. K., Doerrler, W., Dinarello, C. A., and Grunfeld, C. (1992). Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J. Lipid Res. 33, 1765-1776.
15. 14C-lipopolysaccharide by isolated rat Kupffer cells. Gastroenterology 96, 456-461.
16. Galanos, C., Freudenberg, M. A., and Reutter, W. (1979). Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad Sci. U S A 76, 5939-5943.
17. Ganey, P. E., Bailie, M. B., VanCise, S., Colligan, M. E., Madhukar, B. V., Robinson J. P., and Roth, R. A. (1994). Activated neutrophils from rat injured isolated hepatocytes. Lab. Invest. 70, 53-60.
18. Han, J., Thompson, P., and Beutler, B. (1990). Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J. Exper. Med. 172, 391-394.
19. Hansen, J., Cherwitz, D. L., and Allen, J. I. (1994). The role of tumor necrosis factor-alpha in acute endotoxin-induced hepatotoxicity in ethanol-fed rats. Hepatotogy 20, 461-474.
20. Hewett, J. A., Jean, P. A., Kunkel, S. L., and Roth, R. A. (1993). Relationship between tumor necrosis factor-α and neutrophils in endotoxin-induced liver injury. Am. J. Physiol. 265, G1011-G1015.
21. Hewett, J. A., Schultze, A. E., VanCise, S., and Roth, R. A. (1992). Neutrophil depletion protects against liver injury from bacterial endotoxin. Lab. Invest. 66, 347-361.
22. Hirata, K., Kaneko, A., Ogawa, K., Hayasaka, H., and Onoe, T. (1980). Effect of endotoxin on rat liver. Analysis of acid phosphatase isozymes in the liver of normal and endotoxin-treated rats. Lab. Invest. 43, 165-171.
23. Ho, J. S., Buchweitz, J. P., Roth, R. A., and Ganey, P. E. (1996). Identification of factors from rat neutrophils responsible for cytotoxicity to isolated hepatocytes. J. Leukoc. Biol. 59, 716-724.
24. Iimuro, Y., Yamamoto, M., Kohno, H., Itakura, J., Fujii, H., and Matsumoto, Y. (1994). Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxemic rats - analysis of mechanisms of lethality in endotoxemia. J. Leukoc. Biol. 55, 723-728.
25. Jaeschke, H., Farhood, A., and Smith C. W. (1991). Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am. J. Physiol. 261, G1051-G1056.
26. Jones, E. A., and Summerfeild, J. A. (1988). Kupffer cells. In The Liver Biology and Pathophysiology, 2nd ed. (I. M. Arias, W. B. Jakoby, H. Popper, D. Schachter, and D. A. Shafritz, Eds.), pp. 683-704. Raven Press, New York.
27. Klaunig, J. E., Goldblatt, P. J., Hinton, D. E., Lipsky, M. M., Chacko, J., and Trump, B. F. (1981). Mouse liver cell culture: I. Hepatocyte isolation. In Vitro 17, 913-925.
28. Kowalski, J., Kosmider, M., Pasnik, J., Zeman, K., Baj, Z., Janiszewska-Drobinska, B., and Czekalska, R. (1999). Pentoxifylline decreases neutrophil respiratory bursts in patients with stable angina. Fundam. Clin. Pharmacol. 13, 237-242.
29. Krebs, H. A., Freeland, R. A., Hems, R., and Stubbs, M. (1969). Inhibition of hepatic gluconeogenesis by ethanol. Biochem. J. 112, 117-124.
30. Lind, R. C., Gandolfi, A. J., Sipes, I. G., and Brown, B. R., Jr. (1984). The involvement of endotoxin in halothane-associated liver injury. Anesthesiology 61, 544-550.
31. Miyazaki, H., Broaddus, V. C., Wiener-Kronish, J. P., Sawa, T., Pittet, J. F., Kravchenko, V., Mathison, J. C., Nishizawa, H., Hattori, S., Yamakawa, T., Yamada, H., and Kudoh, I. (1999). The effects of two anti-inflammatory pretreatments on bacterial-induced lung injury. Anesthesiology 90, 1650-1662.
32. Noel, P., Nelson, S., Bokulic, R., Bagby, G., Lippton, H., Lipscomb, G., and Summer, W. (1990). Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality. Life Sci. 47, 1023-1029.
33. Pearson, J. M., Bailie, M. B., Fink, G. D., and Roth, R. A. (1997). Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration. Toxicology 121, 181-189.
34. Raetz, C. R., Brozek, K. A., Clementz, T., Coleman, J. D., Galloway, S. M., Golenbock, D. T., and Hampton, R. Y. (1988). Gram-negative endotoxin: a biologically active lipid. Cold Spring Harb. Symp. Quant. Biol. 53, 973-982.
35. Raetz, C. R., Ulevitch, R. J., Wright, S. D., Sibley, C. H., Ding, A., and Nathan, C. F. (1991). Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 5, 2652-2660.
36. Reuter, B. K., and Wallace, J. L. (1999). Phosphodiesterase inhibitors prevent NSAID enteropathy independently of effects on TNFα release. Am. J. Physiol. 277, G847-G854.
37. Rietschel, E. T., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zahringer, U., Seydel, U., Di Padova, F., Schreier, M., and Brade, H. (1994). Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8, 217-225.
38. Sato, T., Shinzawa, H., Abe, Y., Takahashi, T., Arai, S., and Sendo, F. (1993). Inhibition of Corynebacterium parvum-primed and lipopolysaccharide-induced hepatic necrosis in rats by selective depletion of neutrophils using a monoclonal antibody. J. Leukoc. Biol. 53, 144-150.
39. Seglen, P. O. (1973). Preparation of rat liver cells: III.. Enzymatic requirements for tissue dispersion. Exp. Cell Res. 82, 391-398.
40. Semmler, J., Gebert, U., Eisenhut, T., Moeller, J., Schonharting, M. M., Allera, A., and Endres, S. (1993). Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology 78, 520-525.
41. Shibayama, Y. (1987). Sinusoidal circulatory disturbance by microthrombosis as a cause of endotoxin-induced hepatic injury. J. Pathol. 151, 315-321.
42. Sieg, D. J., and Billings, R. E. (1997). Lead/cytokine-mediated oxidative DNA damage in cultured mouse hepatocytes. Toxicol. Appl. Pharmacol. 142, 106-115.
43. Siegel, J. H., Goodzari, S., Guadelupi, P., Coleman, W. P., Malcolm, D., Blevins, S., Frankenfield, D., Badellino, M. C., Boetker, T., and Duek, S. D. (1993). The host defense to trauma and sepsis: multiple organ failure as a manifestation of host defense failure disease. In Pathophysiology of Shock, Sepsis and Organ Failure (H. Schlag and H. Redl., Eds.), pp. 626-664. Springer-Verlag, Berlin.
44. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
45. Sneed, R. A., Grimes S. D., Schultze A. E., Brown, A. P., and Ganey, P. E. (1997). Bacterial endotoxin enhances the hepatotoxicity of allyl alcohol. Toxicol. Appl. Pharmacol. 144, 77-87.
46. Taffet, S. M., Singhel, K. J., Overholtzer, J. F., and Shurtleff, S. A. (1989). Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP. Cell. Immunol. 120, 291-300.
47. Toth, C. A., and Thomas, P. (1992). Liver endocytosis and Kupffer cells. Hepatology 16, 255-266.
48. Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., and Cerami, A. (1987). Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330, 662-664.
49. Utili, R., Abernathy, C. O., and Zimmerman, H. J. (1977). Endotoxin effects on the liver. Life Sci. 20, 553-568.
50. Wang, J. H., Redmond, H. P., Watson, R. W., and Bouchier-Hayes, D. (1995). Role of lipopolysaccharide and tumor necrosis factor-alpha in induction of hepatocyte necrosis. Am. J. Physiol. 269, G297-G304.
51. Ward, A., and Clissold, S. P. (1987). Pentoxifylline: A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34, 50-97.
52. Watson, R. W., Redmond, H. P., and Bouchier-Hayes, D. (1994). Role of endotoxin in mononuclear phagocyte-mediated inflammatory responses. J. Leukoc. Biol. 56, 95-103.
53. Wisse, E., Braet, F., Luo, D., De Zanger, R., Jans, D., Crabbe, E., and Vermoesen, A. (1996). Structure and function of sinusoidal lining cells in the liver. Toxicol. Pathol. 24, 100-111.
54. Wroblewski, F., and LaDue, J. S. (1956). Serum glutamic-pyruvic transaminase in cardiac hepatic disease. Proc. Soc. Exp. Biol. Med. 91, 569.
55. Wu, C. C., Liao, M. H., Chen, S. J., and Yen, M. H. (1999). Pentoxifylline improves circulatory failure and survival in murine models of endotoxaemia. Eur. J. Pharmacol. 373, 41-49.
56. Yang, S., Zhou, M., Koo, D. J., Chaudry, I. H., and Wang, P. (1999). Pentoxifylline prevents the transition from the hyperdynamic to hypodynamic response during sepsis. Am. J. Physiol. 277, H1036-H1044.
57. Zabel, P., Schade, F. U., and Schlaak, M. (1993). Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 187, 447-463.
58. Zabel, P., Wolter, D. T., Schonharting, M, M., and Schade, U. F. (1989). Oxpentifylline in endotoxaemia. Lancet 2, 1474-1477.